Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0026764 (
multiple myeloma
)
36,148
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
This study presents evidence on the occurrence of an inverse relationship between activation of glycogen synthetase and inactivation of
phosphorylase
in a platelet preparation in vitro. The activities of glycogen synthetase and
phosphorylase
and the pattern of changes in these activities in platelets from controls and
multiple myeloma
patients were compared. Platelets obtained from
multiple myeloma
patients were shown to have an increased glycogen content, accompanied by an elevated level of glycogen synthetase a and a decreased activity of
phosphorylase
a. The pattern of changes in these enzyme activities during incubation was also different in platelets of controls and
multiple myeloma
patients. Extracts from patients' platelets prevented glycogen synthetase activation and
phosphorylase
inactivation of control platelets. Preincubation of platelets from
multiple myeloma
patients in control plasma resulted in an increased rate of glycogen synthetase activation, and abolished activation of
phosphorylase
which was found after preincubation in autologous plasma.
...
PMID:Abnormal platelet glycogen metabolism in multiple myeloma patients. 40 57
The spleen cells of a Balb/c mouse immunized with purified bovine calmodulin-dependent cyclic nucleotide phosphodiesterase were fused with nonsecreting mouse
myeloma
cells (P3-X63-Ag8-653). Antibody producing hybridomas were screened by the enzyme-linked immunosorbent assay using purified phosphodiesterase as the antigen. One monoclonal cell line, CR-B1, was found to produce antibodies which showed positive enzyme-linked immunosorbent assay reactions with bovine brain calcineurin and rabbit
muscle phosphorylase
kinase in addition to phosphodiesterase. The antibody was purified and characterized. It was shown to immunoprecipitate the calmodulin (CaM)-dependent phosphodiesterase and phosphorylase kinase activities but not those of CaM itself, CaM-independent phosphodiesterase and the catalytic unit of cAMP-dependent protein kinase. The immunoprecipitation of phosphodiesterase could be inhibited by calcineurin and phosphorylase kinase. These results suggest that the antibody interacts at a common site on these calmodulin-dependent proteins. The antigenic determinant in phosphodiesterase does not appear to reside in the calmodulin-binding domain of the enzyme since the antibody and phosphodiesterase interaction is not inhibited by calmodulin, and the calmodulin activation of phosphodiesterase is not affected by CR-B1 antibody. It is therefore suggested that the structural similarity among the three calmodulin-dependent proteins extends beyond the calmodulin-binding domains.
...
PMID:A monoclonal antibody showing cross-reactivity toward three calmodulin-dependent enzymes. 631 38
Rabbit skeletal muscle protein phosphatases C-I and C-II have been previously isolated as two proteins of Mr = approximately 35,000. Both enzymes display broad substrate specificities but have distinct enzymatic properties in regard to their susceptibility to heat-stable protein inhibitor-2 and their response to divalent cations. Monoclonal antibodies against both protein phosphatase C-I and C-II were produced by fusion of spleen cells of immunized BALB/c mice with SP2/0-Ag14 mouse
myeloma
cells. The products of the hybrid cells were screened by solid phase radioimmunoassay for the production of antibodies to protein phosphatase C-I and C-II. Positive cells were cloned and injected into mice to produce ascitic fluids. Ten monoclonal antibodies against phosphatase C-I and eight monoclonal antibodies against phosphatase C-II were obtained. These antibodies were characterized with regard to their relative binding affinities to the two protein phosphatases and their abilities to inhibit the
phosphorylase
phosphatase activities of the two enzymes. All ten of the phosphatase C-I monoclonal antibodies inhibited the
phosphorylase
phosphatase activity of phosphatase C-I, and three of these also inhibited phosphatase C-II. Only one of the eight antibodies to phosphatase C-II was inhibitory and inhibited the activities of both phosphatase C-I and C-II. Examination of the binding of these monoclonal antibodies by a solid phase radioimmunoassay showed that eight of the ten phosphatase C-I antibodies cross-reacted with phosphatase C-II, while all eight of the phosphatase C-II antibodies cross-reacted with phosphatase C-I. These findings show that phosphatases C-I and C-II possess common antigenic determinant(s) and may, therefore, be structurally related proteins.
...
PMID:Monoclonal antibodies to rabbit skeletal muscle protein phosphatases C-I and C-II. 632 26